Phenotype of DCact and DCact-Fb on coculture with fibroblasts
. | DCact . | DCact-Fb . |
---|---|---|
HLA-DR, percentage | 97.8 ± 1.3 | 96.8 ± 3 |
HLA-DR, mean | 102 ± 39 | 92 ± 28 |
CD1c, percentage | 48.6 ± 16 | 46.6 ± 15 |
iNOS, percentage | 36 ± 3 | 27 ± 6.9 |
TNF-α, pg/mL | 3020 ± 1608 | 1188 ± 502* |
IL-23, pg/mL | 210 ± 85 | 722 ± 160† |
IL-12, pg/mL | 38 ± 15 | 67 ± 26† |
IL-6, pg/mL | 24 250 ± 6339 | 120 092 ± 38 586† |
IL-1β, pg/mL | 178 ± 113 | 107 ± 74 |
TGF-β, pg/mL | 168 ± 184 | 247 ± 350 |
. | DCact . | DCact-Fb . |
---|---|---|
HLA-DR, percentage | 97.8 ± 1.3 | 96.8 ± 3 |
HLA-DR, mean | 102 ± 39 | 92 ± 28 |
CD1c, percentage | 48.6 ± 16 | 46.6 ± 15 |
iNOS, percentage | 36 ± 3 | 27 ± 6.9 |
TNF-α, pg/mL | 3020 ± 1608 | 1188 ± 502* |
IL-23, pg/mL | 210 ± 85 | 722 ± 160† |
IL-12, pg/mL | 38 ± 15 | 67 ± 26† |
IL-6, pg/mL | 24 250 ± 6339 | 120 092 ± 38 586† |
IL-1β, pg/mL | 178 ± 113 | 107 ± 74 |
TGF-β, pg/mL | 168 ± 184 | 247 ± 350 |
DCs were preactivated with LPS and afterward cocultured without (DCact) and with fibroblasts (DCact-Fb) overnight. HLA-DR (percentage positive cells and mean), CD11c, and iNOS (percentage positive cells) were measured by flow cytometry. IL-23, IL-12, IL-6, TGF-β, IL-1β, and TNF-α protein levels were measured by ELISA.
P < .05 vs DCact (n = 3 independent experiments).
P < .001 vs DCact (n = 3 independent experiments).